Informations générales (source: ClinicalTrials.gov)
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Observational
Federation Francophone de Cancerologie Digestive (Voir sur ClinicalTrials)
mars 2024
février 2031
18 septembre 2025
The aim of this French multicenter retrospective study is to describ rare primary hepatic
cancers clinical, histological and radiological features, to obtain a biological tumor
and blood collection, and to evaluate the efficacy of treatments received in clinical
practice in order to determine optimal therapeutic sequences. This retrospective cohort
will be the backbone of future translational studies aimed at identifying new molecular,
histological, circulating and radiological tumor biomarkers, potentially useful at every
stage of diagnosis and prognostic or theranostic evaluation.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Alice BOILEVE | 18/05/2026 07:55:05 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Avicenne | JEAN CHARLES NAULT, PR | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Beaujon | MOHAMED BOUATTOUR, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | HELENE REGNAULT, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Saint Antoine | MARIE LEQUOY, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP - HP - Pitié Salpêtrière - 75651 - Paris - France | MANON ALLAIRE, MD | Contact (sur clinicalTrials) | |||
| CAC - Eugène Marquis - 35042 - Rennes - France | JULIEN EDELINE, MD | Contact (sur clinicalTrials) | |||
| Centre Hospital Universitaire de lille - 59000 - Lille - France | Emmanuel Boleslawski, pr | Contact (sur clinicalTrials) | |||
| Centre Hospitalier - Calais - France | Nathalie IBRAHIM | Contact (sur clinicalTrials) | |||
| Centre Hospitalier de Perpignan - 66046 - Perpignan - France | Faiza Khemissa-Akouz, PhD | Contact (sur clinicalTrials) | |||
| Centre Léon Berard - 69008 - Lyon - France | aurelien dupre | Contact (sur clinicalTrials) | |||
| CH - Annecy Genevois - 74374 - Pringy - France | Emmanuel Maillard, md | Contact (sur clinicalTrials) | |||
| Ch - Centresimone Veil de Beauvais - 60021 - Beauvais - France | HANIFA AMMARGUELLAT, MD | Contact (sur clinicalTrials) | |||
| Ch Bethune Beuvry - 62408 - Bethune - France | Helene VAN DAMME, MD | Contact (sur clinicalTrials) | |||
| Ch Edouard Herriot - 69002 - Lyon - France | JEROME DUMORTIER, MD | Contact (sur clinicalTrials) | |||
| CHR - Metz Thionville Hopital de Mercy - 57085 - Metz - France | Guillaume CONROY | Contact (sur clinicalTrials) | |||
| Chru de Tours - 37044 - Tours - France | ANAIS JAILLAIS, MD | Contact (sur clinicalTrials) | |||
| CHU - 21079 - Dijon - France | MARIANNE LATOURNERIE, MD | Contact (sur clinicalTrials) | |||
| CHU Amiens picardie - 80054 - Amiens - France | eric NGUYEN KHAC, MD | Contact (sur clinicalTrials) | |||
| Chu Angers - 49933 - Angers - France | FREDERIC OBERTI, MD | Contact (sur clinicalTrials) | |||
| Chu de La Timone - 13385 - Marseille - France | RENE GEROLAMI, MD | Contact (sur clinicalTrials) | |||
| Chu de Poitiers - 86021 - Poitiers - France | DAVID TOUGERON, PR | Contact (sur clinicalTrials) | |||
| Chu Edouard Herriot - Lyon - France | Jérôme DUMORTIER | Contact (sur clinicalTrials) | |||
| Chu Grenobles Alpes - 38700 - La Tronche - France | BLEUENN BRUSSET, MD | Contact (sur clinicalTrials) | |||
| Chu Jean Minjoz - Besançon - France | Angelique VIENOT | Contact (sur clinicalTrials) | |||
| CHU La Source - Orléans - France | Barbara DAUVOIS | Contact (sur clinicalTrials) | |||
| Chu Rangueil - Toulouse - France | Jean-Marie PERON, Pr | Contact (sur clinicalTrials) | |||
| Chu Robert Debre - 51000 - Reims - France | ELIA GIGANTE, MD | Contact (sur clinicalTrials) | |||
| Cote de Nacre - Caen - France | Isabelle OLLIVIER HOURMAND | Contact (sur clinicalTrials) | |||
| Groupe Hospitalier Rance Emeraude - 35403 - Saint-Malo - France | VIAUD JULIETTE, Dr | Contact (sur clinicalTrials) | |||
| Gustave Roussy - Villejuif - France | Alice BOILEVE, Dr | Contact (sur clinicalTrials) | |||
| Hopital Haut Leveque - 33604 - Pessac - France | JEAN FREDERIC BLANC, PR | Contact (sur clinicalTrials) | |||
| Hopital Nord Chu Saint Etienne - Saint-Priest-en-Jarez - France | Jean-Marc PHELIP, Pr | Contact (sur clinicalTrials) | |||
| Hopital Saint Joseph - 13285 - Marseille - France | XAVIER ADHOUTE, MD | Contact (sur clinicalTrials) | |||
| Ico Site Rene Gauducheau - 44805 - Saint-Herblain - France | TIMOTHEE VIGNAUD, DR | Contact (sur clinicalTrials) | |||
| La Clinique de La Sauvegarde - 69009 - Lyon - France | BENJAMIN DARNIS, MD | Contact (sur clinicalTrials) | |||
| Longjumeau Ch Nord Essone - Longjumeau - France | Manal AWAD, MD | Contact (sur clinicalTrials) | |||
| Lyon Cac Leon Berard - Lyon - France | Aurelien DUPRE | Contact (sur clinicalTrials) | |||
| Lyon La Croix Rousse - Lyon - France | Philippe MERLE | Contact (sur clinicalTrials) | |||
| PAU CH - 64000 - Pau - France | JULIETTE THAURY | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- 18 years of age or older,
- with histologically proven hepato-cholangiocarcinoma, fibrolamellar hepatocellular
carcinoma, epithelioid hemangioendothelioma or hepatic angiosarcoma
- diagnosed after January 01, 2018 living or deceased at the time of registration in
the cohort
- for living patients who have not objected to the research: (note of non-objection to
be attached° agreeing to participate in ancillary studies must sign the biological
consent form for participation in biological studies.
- 18 years of age or older,
- with histologically proven hepato-cholangiocarcinoma, fibrolamellar hepatocellular
carcinoma, epithelioid hemangioendothelioma or hepatic angiosarcoma
- diagnosed after January 01, 2018 living or deceased at the time of registration in
the cohort
- for living patients who have not objected to the research: (note of non-objection to
be attached° agreeing to participate in ancillary studies must sign the biological
consent form for participation in biological studies.
- without social security
- No access to tumor block